Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 9 de 9
Filtrar
1.
Arch Bronconeumol (Engl Ed) ; 57(6): 399-405, 2021 Jun.
Artigo em Inglês | MEDLINE | ID: mdl-34088391

RESUMO

INTRODUCTION: Continuous positive airway pressure (CPAP) is one of the most common therapies for Obstructive Sleep Apnea (OSA). We present a brief, patient-reported outcome measure used to assess patients' levels of adherence with CPAP treatment. METHODS: A questionnaire was developed based on academic literature. We qualitatively tested a pool of 18 items. It was tested in a sample of 174 patients from the Hospital La Princesa. Next, 1021 patients from Catalonia were evaluated. RESULTS: 5 items were removed. Nominal groups referred to three areas: general knowledge about OSA and its risks; CPAP treatment information and expectations; CPAP use, monitoring, and confidence with its use. The 13 retained items maintained the same meaning as the original questionnaire (r=.986; p<.001) and the three proposed dimensions detected a significant increase in general knowledge of OSA (t[173]=8.097, p<.001); CPAP treatment information (t[173]=15.170, p<.001); and CPAP use (t[173]=14.642, p<.001). The final 12-item version was reliable (CRI=.793) and its internal structure was adequate (χ2[51]=72.073; p=.027, CFI=.967, RMSEA=.020 [.000, .030]). Women had a better general knowledge of OSA (t[1,018]=2.190, p=.029), CPAP treatment information (t[1,018]=2.920, p=.004), and higher overall OSA-CPAP scores (t[1,018]=3.093, p=.002). Scores were positively related to quality of life and motivation, adherence was positively related to CPAP use and monitoring, and the total score was negatively related to daytime sleepiness. CONCLUSIONS: The interview could help clinicians prevent some dropouts by targeting patients with lower adherence. It's a tool for assessing patient adherence to CPAP and to promote strategies through education and external motivational stimuli.


Assuntos
Distúrbios do Sono por Sonolência Excessiva , Apneia Obstrutiva do Sono , Pressão Positiva Contínua nas Vias Aéreas , Feminino , Humanos , Cooperação do Paciente , Qualidade de Vida , Apneia Obstrutiva do Sono/terapia
2.
Arch. bronconeumol. (Ed. impr.) ; 57(6): 399-405, Jun. 2021. ilus, tab
Artigo em Inglês | IBECS | ID: ibc-208725

RESUMO

Introducción: La presión positiva continua en la vía aérea (CPAP) es uno de los tratamientos más frecuentes para la apnea obstructiva del sueño (AOS). Presentamos una breve medida de resultados percibidos por el paciente para evaluar los niveles de adhesión de los pacientes al tratamiento con CPAP.Métodos: Se desarrolló un cuestionario basado en la literatura académica. Se ensayó cualitativamente un conjunto de 18 ítems en una muestra de 174 pacientes del Hospital La Princesa (Madrid). A continuación se evaluaron 1.021 pacientes de Cataluña.Resultados: Se eliminaron 5 ítems. Los grupos nominales se refirieron a tres áreas: conocimiento general sobre la AOS y sus riesgos; información y expectativas de tratamiento con CPAP; uso de la CPAP, seguimiento y desenvoltura en su manejo. Los 13 ítems conservados mantuvieron el mismo significado que el cuestionario original (r=0,986; p<0,001) y las tres dimensiones propuestas detectaron un aumento significativo en el conocimiento general de la AOS (t[173]=8,097, p<0,001); información sobre el tratamiento con CPAP (t[173]=15,170, p<0,001); y uso de la CPAP (t[173]=14,642, p<0,001). La versión final de 12 ítems fue fiable (CRI=0,793) y su estructura interna fue adecuada (χ2 [51]=72,073; p=0,027, CFI=0,967, RMSEA=0,020 [0,000, 0,030]). Las mujeres mostraron mejor conocimiento general de la AOS (t[1,018]=2,190, p=0,029), de la información sobre el tratamiento con CPAP (t[1,018]=2,920, p=0,004), y obtuvieron mejores puntuaciones globales en la entrevista OSA-CPAP (t[1,018]=3,093, p=0,002). Las puntuaciones se relacionaron positivamente con la calidad de vida y la motivación, la adhesión se relacionó positivamente con el uso y el seguimiento con CPAP, y la puntuación total se relacionó negativamente con la somnolencia diurna. (AU)


Introduction: Continuous positive airway pressure (CPAP) is one of the most common therapies for Obstructive Sleep Apnea (OSA). We present a brief, patient-reported outcome measure used to assess patients’ levels of adherence with CPAP treatment.Methods: A questionnaire was developed based on academic literature. We qualitatively tested a pool of 18 items. It was tested in a sample of 174 patients from the Hospital La Princesa. Next, 1021 patients from Catalonia were evaluated.Results: 5 items were removed. Nominal groups referred to three areas: general knowledge about OSA and its risks; CPAP treatment information and expectations; CPAP use, monitoring, and confidence with its use. The 13 retained items maintained the same meaning as the original questionnaire (r=.986; p<.001) and the three proposed dimensions detected a significant increase in general knowledge of OSA (t[173]=8.097, p<.001); CPAP treatment information (t[173]=15.170, p<.001); and CPAP use (t[173]=14.642, p<.001). The final 12-item version was reliable (CRI=.793) and its internal structure was adequate (χ2[51]=72.073; p=.027, CFI=.967, RMSEA=.020 [.000, .030]). Women had a better general knowledge of OSA (t[1,018]=2.190, p=.029), CPAP treatment information (t[1,018]=2.920, p=.004), and higher overall OSA-CPAP scores (t[1,018]=3.093, p=.002). Scores were positively related to quality of life and motivation, adherence was positively related to CPAP use and monitoring, and the total score was negatively related to daytime sleepiness. (AU)


Assuntos
Humanos , Pessoa de Meia-Idade , Idoso , Apneia Obstrutiva do Sono , Pressão Positiva Contínua nas Vias Aéreas , Motivação , Cooperação do Paciente , Inquéritos e Questionários , Medidas de Resultados Relatados pelo Paciente
3.
Med. interna Méx ; 34(3): 373-380, may.-jun. 2018. tab, graf
Artigo em Espanhol | LILACS | ID: biblio-976079

RESUMO

Resumen: ANTECEDENTES El síndrome metabólico se define como un grupo de afecciones que implican incremento de riesgo de enfermedad cardiovascular y diabetes tipo 2. Su prevalencia va en aumento y es una prioridad preventiva en la comunidad científica. OBJETIVO cuantificar las horas de sueño y conocer el riesgo de síndrome de apnea-hipopnea obstructiva del sueño y su relación con síndrome metabólico en trabajadores. MATERIAL Y MÉTODO Estudio epidemiológico transversal, efectuado en trabajadores de la Administración Pública española durante los reconocimientos de vigilancia periódica de la salud de enero a diciembre de 2015. Se valoró el riesgo de síndrome de apnea-hipopnea obstructiva del sueño mediante los cuestionarios Epworth y Stop-Bang y su influencia en el síndrome metabólico con criterios de la Federación Internacional de Diabetes (IDF) y Adult Treatment Panel III (ATP III). RESULTADOS Se incluyeron 1110 pacientes; se encontró que el número de horas de sueño no guarda relación con la existencia mayor de síndrome metabólico en población trabajadora. La detección de síndrome de apnea-hipopnea obstructiva del sueño con la prueba Epworth y con Stop-Bang mostró relación significativa con la existencia de síndrome metabólico con ambos criterios (IDF y ATP III). CONCLUSIONES El mayor riesgo de síndrome de apnea-hipopnea obstructiva del sueño muestra relación estadística con mayor prevalencia de síndrome metabólico.


Abstract: BACKGROUND Metabolic syndrome includes a group of conditions involving an increased risk of developing cardiovascular disease and type 2 diabetes. Its growing prevalence makes it a preventive priority in the scientific community. OBJECTIVE To quantify sleep hours and to know the risk of sleep apnoea detected and the relationship with the metabolic syndrome in workers. MATERIAL AND METHOD An epidemiological cross-sectional study was done in 1110 workers in the Spanish Public Administration during periodic health surveillance from January to December 2015. The risk of presenting nocturnal apnoea was assessed using Epworth and Stop-Bang questionnaires, and their influence on metabolic syndrome with International Diabetes Federation (IDF) and Adult Treatment Panel III (ATP III) criteria. RESULTS The number of hours of sleep is not related to the greater presence of metabolic syndrome in the working population. The detection of obstructive sleep apnoea-hypopnea syndrome with Epworth and Stop-Bang questionnaires showed significant relationship with metabolic syndrome with IDF and ATP III criteria. CONCLUSIONS The highest risk of obstructive sleep apnoea-hypopnea syndrome assessed shows statistic relation to a higher prevalence of metabolic syndrome.

4.
Rev. Fac. Med. UNAM ; 61(1): 21-25, ene.-feb. 2018. tab, graf
Artigo em Espanhol | LILACS | ID: biblio-957149

RESUMO

Resumen Introducción: El síndrome de apnea hipopnea obstructiva del sueño (SAHOS) es un trastorno del dormir que se caracteriza por obstrucción de la vía aérea durante el sueño. Los factores de riesgo más importantes para este trastorno son la obesidad y la edad. La obstrucción de la vía aérea ocasiona síntomas como ronquido de gran intensidad, pausas en la respiración o sensación de ahogamiento durante el sueño. Por otra parte, se ha descrito en la literatura que el uso de benzodiacepinas empeora el ronquido y las pausas en la respiración, por lo que podría incrementar la duración y severidad del SAHOS. Reporte del caso: Mujer de 74 años de edad que acude a consulta a la Clínica de Sueño de la UNAM por sintomatología anímica, y al interrogarla sobre otros trastornos del dormir refiere ronquido intenso, interrumpido por períodos de silencio y pausas en la respiración, por lo que se le realizó polisomnografía nocturna dividida que arrojó el resultado de SAHOS grave. Discusión: El consumo de benzodiacepinas es muy frecuente en los adultos mayores. En este caso, la paciente llevaba ingiriendo 1.5 mg/día de clonazepam durante 8 años, por lo que podría haber empeorado el SAHOS. Conclusiones: La paciente tenía factores de riesgo para desarrollar el SAHOS. Es necesario estudiar más la asociación entre las benzodiacepinas y el empeoramiento del SAHOS.


Abstract Introduction: Obstructive sleep apnea hypopnea syndrome (OSAHS) is caused by an obstruction in the upper airway during sleep. Obesity and advanced age are main risk factors for OSAHS. The classic symptoms of OSAHS include snoring, apneas and choking during sleep. On the other hand, some scientific literature describes that the consumption of benzodiazepines may worsen the snoring and the severity and duration of OSAHS. Case report: A 74-year-old female reported on her appointment to have mood alterations. When asked about other sleep disorders, she said that she snored loudly, with pauses on her breathing. Therefore, a split night polysomnography was performed which revealed a diagnosis of severe OSAHS. Discussion: Old people are frequent consumers of benzodiazepines. The woman of this study had been taking 1.5 mg of clonazepam per day for the last eight years. This may have worsened the OSAHS. Conclusion: The patient presented risk factors that could lead to OSAHS. It is important to study the relationship between benzodiazepines and the severity of OSAHS.

5.
Rev. chil. neuropsicol. (En línea) ; 12(1): 48-53, ago. 2017. tab
Artigo em Espanhol | LILACS | ID: biblio-908673

RESUMO

Esta investigación tiene como objetivo establecer el perfil neuropsicológico de una paciente quien padece Síndrome de apnea obstructiva junto con Síndrome metabólico, esta interacción la cual actualmente se conoce como Síndrome Z. Mediante un estudio descriptivo de caso único, teniendo en cuenta una batería neuropsicológica previamente determinada, se caracteriza el desempeño cognitivo de un paciente masculino de 34 años con el diagnóstico mencionado. Los datos fueron analizados con la baremación correspondiente a cada prueba, encontrando dificultades cognitivas a nivel de función ejecutiva, especialmente en funciones de la corteza prefrontal dorsolateral. Como conclusión se establece que el síndrome Z se asocia a un trastorno neurocognitivo menor en un adulto joven.


This research aims to establish the neuropsychological profile of a patient suffering from obstructive apnea syndrome along with metabolic syndrome, this interaction is currently known as Z Syndrome. A descriptive study of a single case, considering a neuropsychological battery previously determined, the cognitive performance of a 34-year-old male patient with the mentioned diagnosis is characterized. The data was analyzed with the corresponding standard to each test, finding cognitive difficulties at the level of executive function, especially in functions of the dorsolateral prefrontal cortex. In conclusion, it is established that Z syndrome is associated with a minor neurocognitive disorder in a young adult.


Assuntos
Humanos , Masculino , Adulto , Apneia Obstrutiva do Sono , Síndrome Metabólica , Função Executiva/fisiologia , Testes Neuropsicológicos
6.
Bol. méd. Hosp. Infant. Méx ; 73(4): 278-282, jul.-ago. 2016. tab, graf
Artigo em Espanhol | LILACS | ID: biblio-951236

RESUMO

Resumen: El inicio de la respiración nasal marca un impulso genéticamente determinado para airear las cavidades de la cara o senos paranasales, que a su vez inician su crecimiento y forman el espacio útil transitable desde el punto de vista respiratorio durante el desarrollo del tercio medio facial. Considerando la evidencia de que la obstrucción de la vía aérea superior tiene un rol primordial en la patogénesis de los trastornos respiratorios del sueño, cualquier patología que cause dificultad permanente al flujo aéreo nasal durante la respiración llevará a un hipodesarrollo de la amplitud requerida en esta vía, disminuyendo la estimulación del crecimiento de las cavidades sinusales y alterando el desarrollo del tercio medio facial en su conjunto.


Abstract: The onset of nasal breathing sets a genetically determined impulse to aerate the face cavities or paranasal sinuses, which in turn initiate its growth creating the useful trafficable space for air during the development of the midface. Considering the evidence that the upper airway obstruction has a primary role in the pathogenesis of respiratory sleep disorders, any condition that causes a permanent difficulty to the nasal airflow during breathing will cause hypo-development of the required amplitude in this airway, reducing the growth stimulation of the sinus cavities and altering the development of the midface as a whole.

7.
Bol Med Hosp Infant Mex ; 73(4): 278-282, 2016.
Artigo em Espanhol | MEDLINE | ID: mdl-29421391

RESUMO

The onset of nasal breathing sets a genetically determined impulse to aerate the face cavities or paranasal sinuses, which in turn initiate its growth creating the useful trafficable space for air during the development of the midface. Considering the evidence that the upper airway obstruction has a primary role in the pathogenesis of respiratory sleep disorders, any condition that causes a permanent difficulty to the nasal airflow during breathing will cause hypo-development of the required amplitude in this airway, reducing the growth stimulation of the sinus cavities and altering the development of the midface as a whole.

8.
Rev. colomb. psiquiatr ; 43(3): 134-138, jul.-sep. 2014. ilus, tab
Artigo em Espanhol | LILACS, COLNAL | ID: lil-735105

RESUMO

Introduccióny objetivos: Las alteraciones del sueño parecen tener un efecto negativo en la percepción del dolor o en la aparición de este, por lo que surge el interrogante de si el síndrome de apnea/hipopnea obstructiva del sueño (SAHOS) puede tener algún tipo de relación con la percepción de dolor. El objetivo de este estudio es determinar si la prevalencia de dolor en pacientes sometidos a polisomnografía Métodos: Estudio de corte transversal, en el que se mide con la escala de McGill de dolor la prevalencia de dolor en pacientes a los que se realiza estudio polisomnográfico. Resultados:Se entrevistó a 259 pacientes; se encontró una prevalencia de dolor del 69% y una prevalencia de SAHOS del 81%; en los pacientes con SAHOS, la prevalencia fue del 70% y en los pacientes sin esta enfermedad, del 64%. Conclusiones: Se encontró una alta prevalencia de dolor en esta población, posiblemente relacionada con que era una población muy específica, con la forma de realizar la medición y con no haber controlado por variables como otras enfermedades relacionadas con dolor.


Background and objectives: Sleep disturbances apparently have a negative effect on pain or the appearance of pain itself. This suggests the need to determine whether there could be a relationship between obstructive sleep apnea-hypopnea syndrome (OSAHS) and this phenomenon. The objective of this study was to determine the pain prevalence in a population who underwent polysomnography. Method: A cross-sectional study of patients who underwent polisomnography, pain prevalence was measured with Mcgill pain questionnaire. Results: Data was obtained from 259 patients, and it was found that 69% suffered pain, and there was a prevalence of 81% OSAHS. Those with OSAHS had a 70% pain prevalence, with 64% for those without OSAHS. Conclusions: A high pain prevalence was found this population, possibly related to the characteristic of the population, how the information was gathered, and not controlling for other illnesses related with pain.


Assuntos
Humanos , Masculino , Pessoa de Meia-Idade , Polissonografia , Apneia Obstrutiva do Sono , Percepção da Dor , Apneia , Sono , Síndrome , Medição da Dor , Estudos Transversais
9.
Rev Colomb Psiquiatr ; 43(3): 134-8, 2014.
Artigo em Espanhol | MEDLINE | ID: mdl-26575126

RESUMO

BACKGROUND AND OBJECTIVES: Sleep disturbances apparently have a negative effect on pain or the appearance of pain itself. This suggests the need to determine whether there could be a relationship between obstructive sleep apnea-hypopnea syndrome (OSAHS) and this phenomenon. The objective of this study was to determine the pain prevalence in a population who underwent polysomnography. METHOD: A cross-sectional study of patients who underwent polisomnography, pain prevalence was measured with Mcgill pain questionnaire. RESULTS: Data was obtained from 259 patients, and it was found that 69% suffered pain, and there was a prevalence of 81% OSAHS. Those with OSAHS had a 70% pain prevalence, with 64% for those without OSAHS. CONCLUSIONS: A high pain prevalence was found this population, possibly related to the characteristic of the population, how the information was gathered, and not controlling for other illnesses related with pain.

SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...